Rakkyo (Allium chinense): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Rakkyo work for cardiovascular health?

Rakkyo contains thiosulfinates and flavonoids like quercetin and kaempferol that contribute to its cardiovascular effects. These compounds inhibit platelet aggregation, potentially reducing blood clot formation. The herb's fructooligosaccharides may support healthy cholesterol metabolism and gut health. Traditional use and preliminary laboratory research suggest anti-inflammatory and antioxidant properties, though human clinical trials remain limited (Evidence Level C). The combined action of these bioactive compounds supports its traditional use in Chinese and Korean medicine for cardiovascular wellness.

Can I take Rakkyo with blood thinners like warfarin or aspirin?

Rakkyo may interact with anticoagulant and antiplatelet medications due to its natural blood-thinning properties. The thiosulfinates in Rakkyo inhibit platelet aggregation, potentially increasing bleeding risk when combined with warfarin, aspirin, clopidogrel, or similar medications. Patients taking blood thinners should consult a healthcare provider before consuming medicinal amounts of Rakkyo. This herb should be discontinued at least two weeks before scheduled surgery to reduce bleeding complications. Culinary amounts are generally lower risk but still warrant caution.

What is the recommended dosage of Rakkyo for medicinal use?

Traditional Chinese Medicine recommends 5-15 grams of fresh Rakkyo bulbs daily for cardiovascular support. In Japan and Korea, the herb is commonly consumed as a pickled vegetable in smaller culinary amounts. Standardized extracts are not well-established in clinical research, so whole herb preparations are preferred. Evidence for specific therapeutic dosing is limited (Evidence Level C), and traditional use patterns suggest incorporating it as a regular food rather than a concentrated supplement.

Is Rakkyo safe during pregnancy and breastfeeding?

Rakkyo is considered safe when consumed in normal food amounts during pregnancy and breastfeeding, based on its long history as a dietary staple in East Asian cuisine. However, medicinal doses above typical culinary amounts have not been specifically studied in pregnant populations. Pregnant women should consult healthcare providers before using concentrated or therapeutic amounts. Culinary consumption is generally regarded as safe, though excessive intake may cause gastrointestinal upset in sensitive individuals.

What is Rakkyo used for in traditional Chinese medicine?

Rakkyo, known as Xie Bai in Traditional Chinese Medicine, is primarily used for cardiovascular conditions including chest discomfort and circulation support. Korean traditional medicine similarly employs it for cardiovascular wellness. The herb is classified as a food-medicine, consumed regularly as pickled vegetables in China, Japan, and Korea. Traditional uses also include supporting healthy cholesterol levels and promoting circulation. Evidence supporting these uses is preliminary (Evidence Level C), based largely on traditional practice and laboratory studies rather than clinical trials.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Rakkyo (Allium chinense) is an edible vegetable and medicinal herb used in East Asia, recognized for its potential cardioprotective, anti-inflammatory, and lipid-lowering effects [PMID:36985457, 28911557, 40728972].

Background

Rakkyo (Allium chinense) is a Japanese leek and edible vegetable widely consumed across East Asia [PMID:33803393, 42234991]. It is recognized as a botanical source for the traditional Chinese medicine Allii Macrostemonis Bulbus (Xiebai) [PMID:36985457, 39010119].

Traditional uses

In traditional Chinese medicine, it is used to activate Yang, remove stasis, regulate Qi, and eliminate stagnation [PMID:36985457]. It is often used in some Asian countries to treat coronary heart disease, angina pectoris, asthma, and diarrhea [PMID:36985457].

Active compounds

Key bioactive constituents include steroidal saponins (such as chinenosides II and III) [PMID:27507199, 8588870], phenolic amides (alichinemide I and II) [PMID:38094023], fructans [PMID:41754166, 24485744], volatile sulfur compounds (including allyl methyl sulfide and 1-propanethiol) [PMID:11312859, 25970899], and quercetin glucosides [PMID:29552109].

Mechanism of action

Steroidal saponins may exert antiproliferative effects by suppressing AKT phosphorylation and inducing mitochondrial dysfunction and caspase-dependent apoptosis [PMID:42234991, 32485185]. Certain steroidal glycosides inhibit nitric oxide production by blocking NF-κB nuclear translocation [PMID:42235872]. Its anti-myocardial ischemia-reperfusion injury effects are linked to the inhibition of platelet activation [PMID:40728972].

Clinical evidence

Evidence DHyperlipidemia

Essential-oil extracts significantly reduced serum and hepatic total cholesterol, triglycerides, and LDL levels while increasing HDL levels in high-fat-diet rats [PMID:28911557].

Evidence DPlatelet Aggregation

Extracts (particularly 70% methanol fraction) exhibit inhibitory effects on platelet aggregation induced by ADP, arachidonic acid, and collagen [PMID:42180572].

Evidence DMyocardial Injury

Crude polysaccharides and specific fractions (MT-95ET) reduced myocardial injury and fibrosis in I/R rat models and protected H9c2 myocardial cells in vitro [PMID:38432275, 40728972, 38094023].

Evidence DSkin Health (Fibroblasts)

Rakkyo-derived fructan stimulates the synthesis of collagen and hyaluronan in human dermal fibroblasts [PMID:41754166].

Evidence DGastric Cancer

Specific steroidal saponins (e.g., A-24) show dose-dependent cytotoxicity and induce apoptosis and autophagy in human gastric adenocarcinoma cell lines [PMID:42234991, 32485185].

Evidence summary

The current evidence is primarily based on in vitro cell studies and in vivo animal models (rats, mice, pigs), indicating strong pharmacological potential for cardiovascular and anti-inflammatory applications, but lacks human clinical trial data.

PubMed sources

1.PMID: 38094023 (2023) — Two new phenolic amides from Allium chinense. · Chinese herbal medicines
2.PMID: 33803393 (2021) — Effect of Dietary Supplementation of Immunobiotic Lactiplantibacillusplantarum N14 Fermented Rakkyo (Allium chinense) Pickled Juice on the Immunocompetence and Production Performance of Pigs. · Animals : an open access journal from MDPI
3.PMID: 36985457 (2023) — Allii Macrostemonis Bulbus: A Comprehensive Review of Ethnopharmacology, Phytochemistry and Pharmacology. · Molecules (Basel, Switzerland)
4.PMID: 41754166 (2026) — Rakkyo (Allium chinense)-Derived Fructan Stimulates Collagen and Hyaluronan Synthesis in Human Dermal Fibroblasts. · Nutrients
5.PMID: 11312859 (2001) — Volatile constituents of Chinese chive (Allium tuberosum Rottl. ex Sprengel) and rakkyo (Allium chinense G. Don).

Rakkyo

Sources & Citations

Calculate a safe dose of Rakkyo

Allium triquetrum

Allium stipitatum

Auricularia Auricula

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Evidence summary

PubMed sources

Government sources

Rakkyo

Sources & Citations

Calculate a safe dose of Rakkyo

Related Herbs

Allium triquetrum

Allium stipitatum

Auricularia Auricula

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Evidence summary

PubMed sources

Government sources